Abstract
In a retrospective study comparing direct oral anticoagulants vs warfarin in this population, apixaban's adverse event rate was lower regardless of frailty status.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 407-409 |
| Number of pages | 3 |
| Journal | Journal of Family Practice |
| Volume | 71 |
| Issue number | 10 |
| DOIs | |
| State | Published - 2022 |
| Externally published | Yes |
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Which anticoagulant is safest for frail elderly patients with nonvalvular A-fib?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS